Wessler S, Freiman DG, Ballon JD, Katz JH, Wolff R, Wolf E. Experimental pulmonary embolism with serum-induced thrombi. Am J Pathol 1961; 38: 89–101.
Dalen JE, Banas JrJS, Brooks HL, Evans GL, Paraskos JA, Dexter L. Resolution rate of acute pulmonary embolism in man. N Engl J Med 1969; 280: 1194–1199.
Azarian R, Wartski M, Collignon MAet al. Lung perfusion scans and hemodynamics in acute and chronic pulmonary embolism. J Nucl Med 1997; 38: 980–983.
Kimura H, Okada O, Tanabe Net al. Plasma monocyte chemoattractant protein-1 and pulmonary vascular resistance in chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2001; 164: 319–324.
Tanaka Y, Schuster DP, Davis EC, Patterson GA, Botney MD. The role of vascular injury and hemodynamics in rat pulmonary artery remodeling. J Clin Invest 1996; 98: 434–442.
Fedullo PF, Auger WR, Channick RN, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Clin Chest Med 2001; 22: 561–581.
Moser KM, Braunwald NS. Successful surgical intervention in severe chronic thromboembolic pulmonary hypertension. Chest 1973; 64: 29–35.
Daily PO, Dembitsky WP, Peterson KL, Moser KM. Modifications of techniques and early results of pulmonary thromboendarterectomy for chronic pulmonary embolism. J Thorac Cardiovasc Surg 1987; 93: 221–233.
Brown DL, Bodary AK, Kirby RR. Anesthetic management of pulmonary thromboendarterectomy. Anesthesiology 1984; 61: 197–200.
Jamieson SW, Auger WR, Fedullo PFet al. Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 1993; 106: 116–126.
Mellemkjaer S, Ilkjaer LB, Klaaborg KEet al. Pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension. Ten years experience in Denmark. Scand Cardiovasc J 2006; 40: 49–53.
D'Armini AM, Zanotti G, Vigano M. Pulmonary endarterectomy: the treatment of choice for chronic thromboembolic pulmonary hypertension. Ital Heart J 2005; 6: 861–868.
Klepetko W, Mayer E, Sandoval Jet al. Interventional and surgical modalities of treatment for pulmonary arterial hypertension. J Am Coll Cardiol 2004; 43: 73S–80S.
Jamieson SW, Kapelanski DP, Sakakibara Net al. Pulmonary endarterectomy: experience and lessons learned in 1,500 cases. Ann Thorac Surg 2003; 76: 1457–1462.
Proceedings of the 3rd World Symposium on Pulmonary Arterial Hypertension, Venice, Italy, June 23–25, 2003. J Am Coll Cardiol 2004; 43: 1S–90S.
Jamieson SW, Kapelanski DP. Pulmonary endarterectomy. Curr Probl Surg 2000; 37: 165–252.
Fedullo PF, Auger WR, Kerr KM, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465–1472.
Paw P, Jamieson SW. Pulmonary thromboendarterectomy for the treatment of pulmonary embolism caused by renal cell carcinoma. J Thorac Cardiovasc Surg 1997; 114: 295–297.
Heck JrHA, Gross CM, Houghton JL. Long-term severe pulmonary hypertension associated with right atrial myxoma. Chest 1992; 102: 301–303.
Mayer E, Kriegsmann J, Gaumann Aet al. Surgical treatment of pulmonary artery sarcoma. J Thorac Cardiovasc Surg 2001; 121: 77–82.
Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J 1992; 5: 334–342.
Menzel T, Wagner S, Kramm Tet al. Pathophysiology of impaired right and left ventricular function in chronic embolic pulmonary hypertension: changes after pulmonary thromboendarterectomy. Chest 2000; 118: 897–903.
Moser KM, Auger WR, Fedullo PF. Chronic major-vessel thromboembolic pulmonary hypertension. Circulation 1990; 81: 1735–1743.
Pengo V, Lensing AW, Prins MHet al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257–2264.
Wolf M, Boyer-Neumann C, Parent Fet al. Thrombotic risk factors in pulmonary hypertension. Eur Respir J 2000; 15: 395–399.
Auger WR, Permpikul P, Moser KM. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 1995; 99: 392–396.
Colorio CC, Martinuzzo ME, Forastiero RR, Pombo G, Adamczuk Y, Carreras LO. Thrombophilic factors in chronic thromboembolic pulmonary hypertension. Blood Coagul Fibrin 2001; 12: 427–432.
Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin, and anti-beta2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol 1998; 25: 1313–1319.
Bonderman D, Turecek PL, Jakowitsch Jet al. High prevalence of elevated clotting factor VIII in chronic thromboembolic pulmonary hypertension. Thromb Haemost 2003; 90: 372–376.
Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR. Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension. Circulation 1992; 86: 1241–1248.
Fedullo PF, Rubin LJ, Kerr KM, Auger WR, Channick RN. The natural history of acute and chronic thromboembolic disease: the search for the missing link. Eur Respir J 2000; 15: 435–437.
Lewczuk J, Piszko P, Jagas Jet al. Prognostic factors in medically treated patients with chronic pulmonary embolism. Chest 2001; 119: 818–823.
Egermayer P, Peacock AJ. Is pulmonary embolism a common cause of chronic pulmonary hypertension? Limitations of the embolic hypothesis. Eur Respir J 2000; 15: 440–448.
Langer F, Schramm R, Bauer M, Tscholl D, Kunihara T, Schafers HJ. Cytokine response to pulmonary thromboendarterectomy. Chest 2004; 126: 135–141.
Thistlethwaite PA, Lee SH, Du LLet al. Human angiopoietin gene expression is a marker for severity of pulmonary hypertension in patients undergoing pulmonary thromboendarterectomy. J Thorac Cardiovasc Surg 2001; 122: 65–73.
Fedullo PF, Kerr KM, Auger WR, Jamieson SW, Kapelanski DP. Chronic thromboembolic pulmonary hypertension. Semin Respir Crit Care Med 2000; 21: 563–574.
Auger W, Moser K. Pulmonary flow murmurs: a distinctive physical sign found in chronic pulmonary thromboembolic pulmonary hypertension. Clin Res 1989; 37: 147A.
Ryan KL, Fedullo PF, Davis GB, Vasquez TE, Moser KM. Perfusion scan findings understate the severity of angiographic and hemodynamic compromise in chronic thromboembolic pulmonary hypertension. Chest 1988; 93: 1180–1185.
Auger WR, Fedullo PF, Moser KM, Buchbinder M, Peterson KL. Chronic major-vessel thromboembolic pulmonary artery obstruction: appearance at angiography. Radiology 1992; 182: 393–398.
Bergin CJ, Rios G, King MA, Belezzuoli E, Luna J, Auger WR. Accuracy of high-resolution CT in identifying chronic pulmonary thromboembolic disease. Am J Roentgenol 1996; 166: 1371–1377.
Nicod P, Peterson K, Levine Met al. Pulmonary angiography in severe chronic pulmonary hypertension. Ann Intern Med 1987; 107: 565–568.
Oikonomou A, Dennie CJ, Muller NL, Seely JM, Matzinger FR, Rubens FD. Chronic thromboembolic pulmonary arterial hypertension: correlation of postoperative results of thromboendarterectomy with preoperative helical contrast-enhanced computed tomography. J Thorac Imag 2004; 19: 67–73.
Sompradeekul S, Fedullo P, Kerr IH, Channick RH, Auger W. The role of pulmonary angioscopy in the preoperative assessment of patients with thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 1999; 159: A456.
Dartevelle P, Fadel E, Chapelier Aet al. Angioscopic video-assisted pulmonary endarterectomy for post-embolic pulmonary hypertension. Eur J Cardiothorac Surg 1999; 16: 38–43.
Thistlethwaite PA, Auger WR, Madani MM, Pradhan S, Kapelanski DP, Jamieson SW. Pulmonary thromboendarterectomy combined with other cardiac operations: indications, surgical approach, and outcome. Ann Thorac Surg 2001; 72: 13–17.
Kapitan KS, Buchbinder M, Wagner PD, Moser KM. Mechanisms of hypoxemia in chronic thromboembolic pulmonary hypertension. Am Rev Respir Dis 1989; 139: 1149–1154.
Feinstein JA, Goldhaber SZ, Lock JE, Ferndandes SM, Landzberg MJ. Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 2001; 103: 10–13.
Ghofrani HA, Schermuly RT, Rose Fet al. Sildenafil for long-term treatment of nonoperable chronic thromboembolic pulmonary hypertension. Am J Respir Crit Care Med 2003; 167: 1139–1141.
Sheth A, Park JE, Ong YE, Ho TB, Madden BP. Early haemodynamic benefit of sildenafil in patients with coexisting chronic thromboembolic pulmonary hypertension and left ventricular dysfunction. Vascul Pharmacol 2005; 42: 41–45.
Bonderman D, Nowotny R, Skoro-Sajer Net al. Bosentan therapy for inoperable chronic thrombo-embolic pulmonary hypertension. Chest 2005; 128: 2599–2603.
Hoeper MM, Kramm T, Wilkens Het al. Bosentan therapy for inoperable chronic thromboembolic pulmonary hypertension. Chest 2005; 128: 2363–2367.
Nagaya N, Shimizu Y, Satoh Tet al. Oral beraprost sodium improves exercise capacity and ventilatory efficiency in patients with primary or thromboembolic pulmonary hypertension. Heart 2002; 87: 340–345.
Nagaya N, Sasaki N, Ando Met al. Prostacyclin therapy before pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Chest 2003; 123: 338–343.
Oudiz RJ, Schilz RJ, Barst Ret al. Treprostinil, a prostacyclin analogue, in pulmonary arterial hypertension associated with connective tissue disease. Chest 2004; 126: 420–427.
Olschewski H, Simonneau G, Galie Net al. Inhaled iloprost for severe pulmonary hypertension. N Engl J Med 2002; 347: 322–329.
Kerr KM, Rubin LJ. Epoprostenol therapy as a bridge to pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Chest 2003; 123: 319–320.
Rubin LJ, Badesh DB, Barst Ret al. Bosentan therapy for pulmonary hypertension. N Engl J Med 2002; 346: 896–902.
D'Armini AM, Cattadori B, Monterosso Cet al. Pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension: hemodynamic characteristics and changes. Eur J Cardiothorac Surg 2000; 18: 696–701.
Hartz RS, Byrne JG, Levitsky S, Park J, Rich S. Predictors of mortality in pulmonary thromboendarterectomy. Ann Thorac Surg 1996; 62: 1255–1259.
Thistlethwaite PA, Mo M, Madani MMet al. Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 2002; 124: 1203–1211.
Tscholl D, Langer F, Wendler O, Wilkens H, Georg T, Schafers HJ. Pulmonary thromboendarterectomy – risk factors for early survival and hemodynamic improvement. Eur J Cardiothorac Surg 2001; 19: 771–776.
Hagl C, Khaladj N, Peters Tet al. Technical advances of pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension. Eur J Cardiothorac Surg 2003; 23: 776–781.
Hans P, Bonhomme V. The rationale for perioperative brain protection. Eur J Anaesthesiol 2004; 21: 1–5.
Dartevelle P, Fadel E, Chapelier Aet al. [Pulmonary thromboendarterectomy with video-angioscopy and circulatory arrest: an alternative to cardiopulmonary transplantation and post-embolism pulmonary artery hypertension.] Chirurgie 1998; 123: 32–40.
Rubens FD, Sabloff M, Wells PS, Bourke M. Use of recombinant-hirudin in pulmonary thromboendarterectomy. Ann Thorac Surg 2000; 69: 1942–1943.
Manecke JrGR, Parimucha M, Stratmann Get al. Deep hypothermic circulatory arrest and the femoral-to-radial arterial pressure gradient. J Cardiothorac Vasc Anesth 2004; 18: 175–179.
Edmonds HL, Ganzel BL, Austin EH. Cerebral oximetry for cardiac and vascular surgery. Semin Cardiothorac Vasc Anesth 2004; 8: 147–166.
Vuylsteke A, Feneck RO, Jolin-Mellgard Aet al. Perioperative blood pressure control: a prospective survey of patient management in cardiac surgery. J Cardiothorac Vasc Anesth 2000; 14: 269–273.
Gardeback M, Larsen FF, Radegran K. Nitric oxide improves hypoxaemia following reperfusion oedema after pulmonary thromboendarterectomy. Br J Anaesth 1995; 75: 798–800.
Pinelli G, Mertes PM, Carteaux JPet al. Inhaled nitric oxide as an adjunct to pulmonary thromboendarterectomy. Ann Thorac Surg 1996; 61: 227–229.
Imanaka H, Miyano H, Takeuchi M, Kumon K, Ando M. Effects of nitric oxide inhalation after pulmonary thromboendarterectomy for chronic pulmonary thromboembolism. Chest 2000; 118: 39–46.
Moser KM, Bloor CM. Pulmonary vascular lesions occurring in patients with chronic major vessel thromboembolic pulmonary hypertension. Chest 1993; 103: 685–692.
Baskett RJ, Ghali WA, Maitland A, Hirsch GM. The intraaortic balloon pump in cardiac surgery. Ann Thorac Surg 2002; 74: 1276–1287.
Darrah WC, Sharpe MD, Guiraudon GM, Neal A. Intraaortic balloon counterpulsation improves right ventricular failure resulting from pressure overload. Ann Thorac Surg 1997; 64: 1718–1723.
Arafa OE, Geiran OR, Andersen K, Fosse E, Simonsen S, Svennevig JL. Intraaortic balloon pumping for predominantly right ventricular failure after heart transplantation. Ann Thorac Surg 2000; 70: 1587–1593.
Nordhaug D, Steensrud T, Muller S, Husnes KV, Myrmel T. Intraaortic balloon pumping improves hemodynamics and right ventricular efficiency in acute ischemic right ventricular failure. Ann Thorac Surg 2004; 78: 1426–1432.
Dartevelle P, Fadel E, Mussot Set al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637–648.
Kramm T, Eberle B, Guth S, Mayer E. Inhaled iloprost to control residual pulmonary hypertension following pulmonary endarterectomy. Eur J Cardiothorac Surg 2005; 28: 882–888.
Kramm T, Eberle B, Krummenauer F, Guth S, Oelert H, Mayer E. Inhaled iloprost in patients with chronic thromboembolic pulmonary hypertension: effects before and after pulmonary thromboendarterectomy. Ann Thorac Surg 2003; 76: 711–718.
Levinson RM, Shure D, Moser KM. Reperfusion pulmonary edema after pulmonary artery thromboendarterectomy. Am Rev Respir Dis 1986; 134: 1241–1245.
Lee KC, Cho YL, Lee SY. Reperfusion pulmonary edema after pulmonary endarterectomy. Acta Anaesthesiol Sin 2001; 39: 97–101.
Loubser PG. Case 3 – 1998. Pulmonary reperfusion edema associated with pulmonary thromboendarterectomy. J Cardiothorac Vasc Anesth 1998; 12: 353–357.
Fadel E, Mazmanian GM, Chapelier Aet al. Lung reperfusion injury after chronic or acute unilateral pulmonary artery occlusion. Am J Respir Crit Care Med 2004; 157: 1294–1300.
Kerr KM, Auger WR, Marsh JJet al. The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy. Am J Respir Crit Care Med 2000; 162: 14–20.
Mares P, Gilbert TB, Tschernko EMet al. Pulmonary artery thromboendarterectomy: a comparison of two different postoperative treatment strategies. Anesth Analg 2000; 90: 267–273.
Wragg RE, Dimsdale JE, Moser KM, Daily PO, Dembitsky WP, Archibald C. Operative predictors of delirium after pulmonary thromboendarterectomy. A model for postcardiotomy delirium? J Thorac Cardiovasc Surg 1988; 96: 524–529.
Sakamaki F, Kyotani S, Nagaya N, Sato N, Oya H, Nakanishi N. Increase in thrombomodulin concentrations after pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension. Chest 2003; 124: 1305–1311.
Nagaya N, Ando M, Oya Het al. Plasma brain natriuretic peptide as a noninvasive marker for efficacy of pulmonary thromboendarterectomy. Ann Thorac Surg 2002; 74: 180–184.
Manecke JrGR, Kotzur A, Atkins Get al. Massive pulmonary hemorrhage after pulmonary thromboendarterectomy. Anesth Analg 2004; 99: 672–675.
Cerveri I, D'Armini AM, Vigano M. Pulmonary thromboendarterectomy almost 50 years after the first surgical attempts. Heart 2003; 89: 369–370.
Manecke JrGR, Wilson WC, Auger WR, Jamieson SW. Chronic thromboembolic pulmonary hypertension and pulmonary thromboendarterectomy. Semin Cardiothorac Vasc Anesth 2005; 9: 189–204.
Archibald CJ, Auger WR, Fedullo PFet al. Long-term outcome after pulmonary thromboendarterectomy. Am J Respir Crit Care Med 1999; 160: 523–528.
Archibald CJ, Auger WR, Fedullo PF. Outcome after pulmonary thromboendarterectomy. Semin Thorac Cardiovasc Surg 1999; 11: 164–171.
Menzel T, Kramm T, Wagner S, Mohr-Kahaly S, Mayer E, Meyer J. Improvement of tricuspid regurgitation after pulmonary thromboendarterectomy. Ann Thorac Surg 2002; 73: 756–761.
Kapitan KS, Clausen JL, Moser KM. Gas exchange in chronic thromboembolism after pulmonary thromboendarterectomy. Chest 1990; 98: 14–19.
Tanabe N, Okada O, Nakagawa Yet al. The efficacy of pulmonary thromboendarterectomy on long-term gas exchange. Eur Respir J 1997; 10: 2066–2072.
Zoia MC, D'Armini AM, Beccaria Met al. Mid term effects of pulmonary thromboendarterectomy on clinical and cardiopulmonary function status. Thorax 2002; 57: 608–612.
Bernstein RJ, Ford RL, Clausen JL, Moser KM. Membrane diffusion and capillary blood volume in chronic thromboembolic pulmonary hypertension. Chest 1996; 110: 1430–1436.
Barzaghi N, Maurelli M, Emmi Vet al. Pulmonary thromboendarterectomy in a patient with cryoagglutinins. J Cardiothorac Vasc Anesth 2000; 14: 447–448.
Murali B, Drain A, Seller D, Dunning J, Vuylsteke A. Pulmonary thromboendarterectomy in a case of hereditary stomatocytosis. Br J Anaesth 2003; 91: 739–741.
Yung GL, Channick RN, Fedullo PFet al. Successful pulmonary thromboendarterectomy in two patients with sickle cell disease. Am J Respir Crit Care Med 1998; 157: 1690–1693.
Vocelka CR, Lindley GG, Mulligan MS. Cardiopulmonary bypass with deep hypothermic circulatory arrest for a patient with sickle cell anemia: a case report. J Extra Corpor Technol 2001; 33: 243–244.